Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Biodefense and Emerging Infectious Diseases News and Events


Oct. 13, 2015

Media Availability: Antiviral Favipiravir Successfully Treats Lassa Virus in Guinea Pigs

Aug. 28, 2014

NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Aug. 13, 2014

Media Availability: Ebola Outbreak Highlights Global Disparities in Healthcare Resources

Aug. 28, 2013

Media Availability: NIH Scientists Describe How Anthrax Toxins Cause Illness, Death

Oct. 18, 2012

Could a Blood Test Predict Protective Ability of Anthrax Vaccines in Humans?

Dec. 20, 2011

Chikungunya Vaccine Trial Begins Enrollment

Oct. 19, 2011

Antibody Treatment Protects Monkeys from Hendra Virus Disease

Oct. 13, 2011

NIH Funds Development of New Broad-Spectrum Therapeutics

Oct. 7, 2011

Experimental Vaccine Protects Monkeys from Blinding Trachoma

Oct. 4, 2011

Priming with DNA Vaccine Makes Avian Flu Vaccine Work Better

Sept. 19, 2011

Many Viruses Stopped by New Kind of Drug

Sept. 6, 2011

Media Availability: New TB Vaccine Approach Shows Promise in Mice

Aug. 16, 2011

Any Prime-Boost Mix of Injected or Spray Flu Vaccine Shields Toddlers

Aug. 11, 2011

Media Availability: Scientists Explain Unique Activity of TB Drug Pyrazinamide

May 9, 2011

Media Availability: NIH Study Describes Fast, Sensitive Blood Test for Human Prion Disease

April 27, 2011

Leprosy in U.S. May Be Transmitted by Armadillos, Study Finds

April 13, 2011

Media Availability: Increased Prevention Efforts May Not Reduce Spread of Hospital-Based Bacteria

Feb. 8, 2011

Media Availability: NIH, CDC and PAHO To Hold Scientific Meeting in Puerto Rico on Dengue in the Americas

Jan. 25, 2011

Media Availability: Collaboration Fuels Promising New Approach to a TB Vaccine

Jan. 12, 2011

Web Bulletin: Antibodies Identified after 2009 H1N1 Infection Neutralize Multiple Flu Virus Strains

Nov. 17, 2010

NIH Scientists Show how Anthrax Bacteria Impair Immune Response

Oct. 7, 2010

NIH Funds Advanced Development of Three Biodefense Vaccines

Aug. 19, 2010

NIH Renews Major Research Program to Develop Medical Countermeasures Against Radiological and Nuclear Threats

May 20, 2010

Experimental Vaccine Protects Monkeys from New Ebola Virus

May 13, 2010

Improving Treatments for Botulism

Nov. 12, 2009

NIAID Announces New Award to Study the Effects of Radiation and Aging on the Human Immune System

Nov. 4, 2009

NIAID Announces New Human Immunology Research Awards to Help Fight Emerging Infectious Diseases

June 8, 2009

NIAID Renews Funding for National Emerging Infectious Diseases Research Network

Feb. 18, 2009

Novel Way Found to Block Bacterial Toxins

Oct. 5, 2007

HHS Release: HHS Awards Contracts for Advanced Development of New Medical Countermeasures

July 2, 2007

Human Antibodies that Block Human and Animal SARS Viruses Identified

June 6, 2007

NIAID Media Availability: NIAID Releases MDR/XDR Tuberculosis Research Agenda

April 18, 2007

HHS Releases Plan for Development and Purchase of Medical Countermeasures

March 8, 2007

HHS Launches New Online Toolkit for Medical Responses to Radiation Emergencies

Dec. 13, 2006

Molecular Structure Reveals How Botulinum Toxin Attaches to Nerve Cells, May Lead to New Therapeutics

Sept. 25, 2006

NIAID Awards $4 Million to Develop Anti-Radiation Treatments

July 12, 2006

New NIAID Program Aims to Model Immune Responses and Key Infectious Diseases

May 3, 2006

NIH Dedicates the C.W. Bill Young Center for Biodefense and Emerging Infectious Diseases

April 26, 2006

Vaccine Given Post-Exposure Protects Monkeys Against Deadly Marburg Virus

April 23, 2006

Scientists Design Potent Anthrax Toxin Inhibitor

Jan. 23, 2006

Mice Studies Illustrate Potential of Chimp/Human Antibodies to Protect Against Smallpox

Oct. 12, 2005

NIAID Awards $47 Million in New Effort to Develop Medical Countermeasures Against Radiological and Nuclear Threats

Oct. 3, 2005

Large Tularemia Vaccine Contracts Among New NIAID Biodefense Awards

July 6, 2005

Scientists Discover How Nipah Virus Enters Cells

June 27, 2005

Cancer Drug Slows Poxvirus in Mice

June 1, 2005

New NIAID Grants Strengthen National Biodefense and Emerging Infectious Diseases Research Network

Feb. 1, 2005

New Way To Block Pox Shows Promise In Lab Study

Nov. 1, 2004

NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases

Oct. 12, 2004

New Study on Smallpox in Monkeys Reveals Tactics of a Killer

Oct. 7, 2004

HHS Awards $232 Million in Biodefense Contracts for Vaccine Development

July 4, 2004

3-D Structure of Anthrax Toxin Complex Solved

May 19, 2004

NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine

March 24, 2004

Mouse Model Mimics Real-World Plague Infection

March 10, 2004

Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox

Nov. 18, 2003

NIAID Ebola Vaccine Enters Human Trial

Sept. 30, 2003

NIAID Funds Construction of Biosafety Laboratories

Sept. 29, 2003

NIAID Reports 'Tremendous Progress' in Biodefense Research

Sept. 17, 2003

$85 Million Awarded for Research on Human Immunity and Biodefense

Sept. 4, 2003

HHS Announces New Regional Centers for Biodefense Research

Sept. 2, 2003

Mouse Study Gives New View of Anthrax Toxin

Aug. 6, 2003

Fast-Acting Ebola Vaccine Protects Monkeys

April 30, 2003

Anthrax Genome Decoded

Feb. 25, 2003

HHS Announces Contracts To Develop Safer Smallpox Vaccines

Jan. 8, 2003

Powerful Technologies Probe Innate Immunity


Oct. 17, 2002

Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories

Oct. 15, 2002

USAMRIID-NIAID Announce Research Partnership at Fort Detrick

Oct. 3, 2002

HHS Announces Contracts for Developing a New Anthrax Vaccine

June 11, 2002

NIAID Expands Vaccine Testing Network

May 9, 2002

Researchers Unravel Anthrax Genome

April 25, 2002

Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium

March 28, 2002

NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply

March 14, 2002

NIAID Unveils Biodefense Research Agenda

Dec. 6, 2001

Dec. 6, 2001

HHS Accelerates Bioterrorism Research

Oct. 23, 2001

NIAID-supported Anthrax studies appearing in the journal Nature

Nov. 29, 2000

Novel Vaccine Protects Monkeys from Ebola Infection


back to top

Last Updated October 13, 2015